Industry: Medical Devices & Consumables
Published Date: 2026-01-15
Pages: 100 Pages
Report ld: 5669036
Request Sample
Customized Report
The global Single Channel Deep Brain Stimulation (DBS) Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Single Channel Deep Brain Stimulation (DBS) Devices competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow blinded studies.
A single-channel deep brain stimulation device offers a sophisticated solution for managing neurological disorders by delivering precise electrical stimulation to specific brain regions. The system's effectiveness depends on meticulous planning, accurate implantation, and continuous monitoring and adjustment to tailor the therapy to each patient's unique needs. Regular follow-ups and maintenance are essential to ensure the device's long-term efficacy and safety.
This report delivers a comprehensive overview of the global Single Channel Deep Brain Stimulation (DBS) Devices market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Single Channel Deep Brain Stimulation (DBS) Devices. The Single Channel Deep Brain Stimulation (DBS) Devices market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Single Channel Deep Brain Stimulation (DBS) Devices market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Single Channel Deep Brain Stimulation (DBS) Devices manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Single Channel Deep Brain Stimulation (DBS) Devices manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Single Channel Deep Brain Stimulation (DBS) Devices sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Single Channel Deep Brain Stimulation (DBS) Devices Market Overview
1.1 Product Definition
1.2 Single Channel Deep Brain Stimulation (DBS) Devices by Type
1.2.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Market Value by Type: 2025 vs 2032
1.2.2 Rechargeable DBS
1.2.3 Non-rechargeable DBS
1.3 Single Channel Deep Brain Stimulation (DBS) Devices by Application
1.3.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Market Value by Application: 2025 vs 2032
1.3.2 Parkinson's Disease
1.3.3 Essential Tremor
1.3.4 Dystonia
1.3.5 Others
1.4 Global Single Channel Deep Brain Stimulation (DBS) Devices Market Size Estimates and Forecasts
1.4.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Revenue 2021–2032
1.4.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales 2021–2032
1.4.3 Global Single Channel Deep Brain Stimulation (DBS) Devices Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Single Channel Deep Brain Stimulation (DBS) Devices Market Competition by Manufacturers
2.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales Market Share by Manufacturers (2021–2026)
2.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Single Channel Deep Brain Stimulation (DBS) Devices Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Single Channel Deep Brain Stimulation (DBS) Devices, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Single Channel Deep Brain Stimulation (DBS) Devices, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Single Channel Deep Brain Stimulation (DBS) Devices, Product Types and Applications
2.7 Global Key Manufacturers of Single Channel Deep Brain Stimulation (DBS) Devices, Date of Entry into the Industry
2.8 Global Single Channel Deep Brain Stimulation (DBS) Devices Market Competitive Situation and Trends
2.8.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Single Channel Deep Brain Stimulation (DBS) Devices Players Market Share by Revenue
2.8.3 Global Single Channel Deep Brain Stimulation (DBS) Devices Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Single Channel Deep Brain Stimulation (DBS) Devices Market Scenario by Region
3.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales by Region: 2021–2032
3.2.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales by Region: 2021–2026
3.2.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales by Region: 2027–2032
3.3 Global Single Channel Deep Brain Stimulation (DBS) Devices Revenue by Region: 2021–2032
3.3.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Revenue by Region: 2021–2026
3.3.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Revenue by Region: 2027–2032
3.4 North America Single Channel Deep Brain Stimulation (DBS) Devices Market Facts & Figures by Country
3.4.1 North America Single Channel Deep Brain Stimulation (DBS) Devices Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Single Channel Deep Brain Stimulation (DBS) Devices Sales by Country (2021–2032)
3.4.3 North America Single Channel Deep Brain Stimulation (DBS) Devices Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Single Channel Deep Brain Stimulation (DBS) Devices Market Facts & Figures by Country
3.5.1 Europe Single Channel Deep Brain Stimulation (DBS) Devices Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Single Channel Deep Brain Stimulation (DBS) Devices Sales by Country (2021–2032)
3.5.3 Europe Single Channel Deep Brain Stimulation (DBS) Devices Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Single Channel Deep Brain Stimulation (DBS) Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Single Channel Deep Brain Stimulation (DBS) Devices Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Single Channel Deep Brain Stimulation (DBS) Devices Sales by Region (2021–2032)
3.6.3 Asia Pacific Single Channel Deep Brain Stimulation (DBS) Devices Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Single Channel Deep Brain Stimulation (DBS) Devices Market Facts & Figures by Country
3.7.1 Latin America Single Channel Deep Brain Stimulation (DBS) Devices Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Single Channel Deep Brain Stimulation (DBS) Devices Sales by Country (2021–2032)
3.7.3 Latin America Single Channel Deep Brain Stimulation (DBS) Devices Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Single Channel Deep Brain Stimulation (DBS) Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Single Channel Deep Brain Stimulation (DBS) Devices Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Single Channel Deep Brain Stimulation (DBS) Devices Sales by Country (2021–2032)
3.8.3 Middle East and Africa Single Channel Deep Brain Stimulation (DBS) Devices Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales by Type (2021–2032)
4.1.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales by Type (2021–2026)
4.1.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales by Type (2027–2032)
4.1.3 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales Market Share by Type (2021–2032)
4.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Revenue by Type (2021–2032)
4.2.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Revenue by Type (2021–2026)
4.2.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Revenue by Type (2027–2032)
4.2.3 Global Single Channel Deep Brain Stimulation (DBS) Devices Revenue Market Share by Type (2021–2032)
4.3 Global Single Channel Deep Brain Stimulation (DBS) Devices Price by Type (2021–2032)
5 Segment by Application
5.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales by Application (2021–2032)
5.1.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales by Application (2021–2026)
5.1.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales by Application (2027–2032)
5.1.3 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales Market Share by Application (2021–2032)
5.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Revenue by Application (2021–2032)
5.2.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Revenue by Application (2021–2026)
5.2.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Revenue by Application (2027–2032)
5.2.3 Global Single Channel Deep Brain Stimulation (DBS) Devices Revenue Market Share by Application (2021–2032)
5.3 Global Single Channel Deep Brain Stimulation (DBS) Devices Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Single Channel Deep Brain Stimulation (DBS) Devices Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medtronic Single Channel Deep Brain Stimulation (DBS) Devices Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Company Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Single Channel Deep Brain Stimulation (DBS) Devices Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Boston Scientific Single Channel Deep Brain Stimulation (DBS) Devices Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Company Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Single Channel Deep Brain Stimulation (DBS) Devices Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Abbott Single Channel Deep Brain Stimulation (DBS) Devices Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Beijing Pins
6.4.1 Beijing Pins Company Information
6.4.2 Beijing Pins Description and Business Overview
6.4.3 Beijing Pins Single Channel Deep Brain Stimulation (DBS) Devices Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Beijing Pins Single Channel Deep Brain Stimulation (DBS) Devices Product Portfolio
6.4.5 Beijing Pins Recent Developments/Updates
6.5 SceneRay
6.5.1 SceneRay Company Information
6.5.2 SceneRay Description and Business Overview
6.5.3 SceneRay Single Channel Deep Brain Stimulation (DBS) Devices Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 SceneRay Single Channel Deep Brain Stimulation (DBS) Devices Product Portfolio
6.5.5 SceneRay Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Single Channel Deep Brain Stimulation (DBS) Devices Industry Chain Analysis
7.2 Single Channel Deep Brain Stimulation (DBS) Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Single Channel Deep Brain Stimulation (DBS) Devices Production Mode & Process Analysis
7.4 Single Channel Deep Brain Stimulation (DBS) Devices Sales and Marketing
7.4.1 Single Channel Deep Brain Stimulation (DBS) Devices Sales Channels
7.4.2 Single Channel Deep Brain Stimulation (DBS) Devices Distributors
7.5 Single Channel Deep Brain Stimulation (DBS) Devices Customer Analysis
8 Single Channel Deep Brain Stimulation (DBS) Devices Market Dynamics
8.1 Single Channel Deep Brain Stimulation (DBS) Devices Industry Trends
8.2 Single Channel Deep Brain Stimulation (DBS) Devices Market Drivers
8.3 Single Channel Deep Brain Stimulation (DBS) Devices Market Challenges
8.4 Single Channel Deep Brain Stimulation (DBS) Devices Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Single Channel Deep Brain Stimulation (DBS) Devices market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 73
USD 4250.00
(Single User License)
The global Single Channel Deep Brain Stimulation (DBS) Devices market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 116
USD 4900.00
(Single User License)
The global market for Single Channel Deep Brain Stimulation (DBS) Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 81
USD 3950.00
(Single User License)
The global Single Channel Deep Brain Stimulation (DBS) Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 127
USD 4900.00
(Single User License)
The global Single Channel Deep Brain Stimulation (DBS) Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 75
USD 4250.00
(Single User License)
The global market for Single Channel Deep Brain Stimulation (DBS) Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 90
USD 3950.00
(Single User License)
The global market for Single Channel Deep Brain Stimulation (DBS) Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 68
USD 2900.00
(Single User License)
Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow blinded studies.
Published Date: 2024-06-27
Pages: 70
USD 2900.00
(Single User License)
Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow blinded studies.
Published Date: 2024-06-27
Pages: 94
USD 4350.00
(Single User License)
Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow blinded studies.
Published Date: 2024-06-27
Pages: 125
USD 4900.00
(Single User License)
The global Single Channel Deep Brain Stimulation (DBS) Devices market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 73
The global Single Channel Deep Brain Stimulation (DBS) Devices market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 116
The global market for Single Channel Deep Brain Stimulation (DBS) Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 81
The global Single Channel Deep Brain Stimulation (DBS) Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 127
The global Single Channel Deep Brain Stimulation (DBS) Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 75
The global market for Single Channel Deep Brain Stimulation (DBS) Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 90
The global market for Single Channel Deep Brain Stimulation (DBS) Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 68
Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow blinded studies.
Published: 2024-06-27
Pages: 70
Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow blinded studies.
Published: 2024-06-27
Pages: 94
Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow blinded studies.
Published: 2024-06-27
Pages: 125
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now